搜索临床试验以:immune response
总计68050个结果
-
University of Crete招聘中
-
University of Pisa招聘中
-
University Hospital, Limoges招聘中
-
H. Lee Moffitt Cancer Center and Research Institute招聘中
-
Known Medicine, Inc.M.D. Anderson Cancer Center; Mayo Clinic; Duke Cancer Institute招聘中
-
Jun Zhang, MD, PhDNilogen Oncosystems招聘中
-
The University of Queensland招聘中
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of South Florida; University... 和其他合作者招聘中
-
Korea University Guro HospitalAjou University School of Medicine; Korean Center for Disease Control and Prevention; Hallym University...招聘中
-
ANRS, Emerging Infectious DiseasesCIRBA, Abidjan, Ivory Coast; SEREFO, Bamako, Mali; BIOLIM/FSS/UL, Lomé, Togo尚未招聘
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); The Arthritis Society, Canada招聘中
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID)招聘中
-
Institut PasteurJanssen Biotech, Inc.招聘中
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; FONCER contre le cancer招聘中
-
Institut CurieMerck Sharp & Dohme LLC招聘中
-
Novartis Pharmaceuticals招聘中狼疮性肾炎法国, 西班牙, 以色列, 火鸡, 美国, 德国, 印度, 匈牙利, 马来西亚, 葡萄牙, 巴西, 中国, 波多黎各, 香港, 墨西哥, 新加坡
-
Maastricht University Medical CenterMerck Sharp & Dohme LLC; Erasmus Medical Center; Medical Center Haaglanden; Albert Schweitzer Hospital 和其他合作者招聘中
-
Catholic University of the Sacred Heart尚未招聘
-
Korea University Guro HospitalKorea University Anam Hospital; Ajou University School of Medicine; Korean Center for Disease... 和其他合作者招聘中
-
Medical University of SilesiaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice招聘中
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn... 和其他合作者招聘中25 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 评估哪种剂量适合使用泰国
-
Boston Children's HospitalChildren's Hospital Colorado; Celiac Disease Foundation招聘中
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France; University of Bordeaux; Programme... 和其他合作者尚未招聘
-
Children's Cancer Hospital Egypt 57357Pfizer; National Research Centre, Egypt尚未招聘
-
University of Roma La SapienzaLucia Stefanini; Stefania Basili招聘中
-
University of Michigan Rogel Cancer Center招聘中
-
St. Jude Children's Research Hospital招聘中癌症 | 血液系统恶性肿瘤 | 实体器官移植 | 造血细胞移植 | 实体瘤恶性肿瘤 | 造血系统--癌症 | 移植相关癌症 | 细胞疗法美国